Algorae Pharmaceuticals Ltd (1AI) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.327x

Based on the latest financial reports, Algorae Pharmaceuticals Ltd (1AI) has a cash flow conversion efficiency ratio of -0.327x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-618.21K ≈ $-437.42K USD) by net assets (AU$1.89 Million ≈ $1.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Algorae Pharmaceuticals Ltd's balance sheet to measure how much of total assets are equity-financed.

Algorae Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Algorae Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Algorae Pharmaceuticals Ltd to evaluate the quality of earnings relative to operating cash generation.

Algorae Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Algorae Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Travis Perkins PLC LSE:TPK	0.110x
EMMERSON PLC O.N. F:4UM	N/A
Yorbeau Resources Inc TO:YRB	-0.014x
Worldwide Healthcare Trust Plc LSE:WWH	-0.002x
Ashmore Group Plc LSE:ASHM	0.038x
Intikeramik Alamasri Industri JK:IKAI	0.041x
Cordoba Minerals Corp V:CDB	14.511x
Netel Holding AB ST:NETEL	0.093x

Annual Cash Flow Conversion Efficiency for Algorae Pharmaceuticals Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Algorae Pharmaceuticals Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see 1AI market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$2.23 Million ≈ $1.58 Million	AU$-785.25K ≈ $-555.61K	-0.352x	-22.91%
2024-06-30	AU$5.31 Million ≈ $3.76 Million	AU$-1.52 Million ≈ $-1.08 Million	-0.287x	+16.52%
2023-06-30	AU$5.78 Million ≈ $4.09 Million	AU$-1.99 Million ≈ $-1.41 Million	-0.343x	+32.16%
2022-06-30	AU$4.03 Million ≈ $2.85 Million	AU$-2.04 Million ≈ $-1.44 Million	-0.506x	+52.31%
2021-06-30	AU$1.38 Million ≈ $974.40K	AU$-1.46 Million ≈ $-1.03 Million	-1.061x	+1.77%
2020-06-30	AU$2.88 Million ≈ $2.04 Million	AU$-3.11 Million ≈ $-2.20 Million	-1.080x	-124.63%
2019-06-30	AU$4.14 Million ≈ $2.93 Million	AU$-1.99 Million ≈ $-1.41 Million	-0.481x	+3.88%
2018-06-30	AU$7.14 Million ≈ $5.05 Million	AU$-3.57 Million ≈ $-2.53 Million	-0.500x	-11.63%
2017-06-30	AU$7.52 Million ≈ $5.32 Million	AU$-3.37 Million ≈ $-2.38 Million	-0.448x	+19.40%
2016-06-30	AU$5.68 Million ≈ $4.02 Million	AU$-3.16 Million ≈ $-2.23 Million	-0.556x	+20.52%
2015-06-30	AU$5.13 Million ≈ $3.63 Million	AU$-3.59 Million ≈ $-2.54 Million	-0.700x	-7056.25%
2014-06-30	AU$8.43 Million ≈ $5.97 Million	AU$-82.44K ≈ $-58.33K	-0.010x	-109.69%
2013-06-30	AU$13.25 Million ≈ $9.38 Million	AU$1.34 Million ≈ $946.01K	0.101x	+158.23%
2012-06-30	AU$14.35 Million ≈ $10.16 Million	AU$-2.49 Million ≈ $-1.76 Million	-0.173x	+79.53%
2011-06-30	AU$6.76 Million ≈ $4.78 Million	AU$-5.72 Million ≈ $-4.05 Million	-0.847x	+9.92%
2010-06-30	AU$6.24 Million ≈ $4.41 Million	AU$-5.86 Million ≈ $-4.15 Million	-0.940x	+8.93%
2009-06-30	AU$5.53 Million ≈ $3.91 Million	AU$-5.70 Million ≈ $-4.04 Million	-1.032x	-111.67%
2008-06-30	AU$11.48 Million ≈ $8.13 Million	AU$-5.60 Million ≈ $-3.96 Million	-0.487x	+87.66%
2007-06-30	AU$1.40 Million ≈ $991.53K	AU$-5.54 Million ≈ $-3.92 Million	-3.951x	-7.34%
2006-06-30	AU$1.80 Million ≈ $1.27 Million	AU$-6.61 Million ≈ $-4.68 Million	-3.681x	-89.36%
2005-06-30	AU$3.14 Million ≈ $2.22 Million	AU$-6.09 Million ≈ $-4.31 Million	-1.944x	-302.54%
2004-06-30	AU$-1.33 Million ≈ $-937.82K	AU$-1.27 Million ≈ $-900.02K	0.960x	--

About Algorae Pharmaceuticals Ltd

AU:1AI Australia Biotechnology

Market Cap

$17.18 Million

AU$24.28 Million AUD

Market Cap Rank

#25584 Global

#1104 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.25